As a holding subsidiary of Tigermed (300347.SZ / 3347.HK) that is one of the top listed medical service company in China, Teddy Clinical Research Laboratory(Teddylab) is an one-stop clinical research laboratory service provider dedicated to drug development-related services to pharmaceutical companies, CROs and research institutions with strict GCP compliance as well as international standards.

Teddylab is CAP accredited and NGSP Level 1 certified central laboratory. We regularly participate the external quality assessment of China Health Planning Commission and Shanghai Clinical Laboratory Center. Until June the 2024, Teddylab has participated more than 700 registered clinical trials ranging from phase I to IV. We have worked together with our clients to pass 32 on-site audits of the National CFDA and supported the marketing launch of 35 new drugs. The therapeutic areas Teddylab has supported including radiopharmaceutical, immunotherapy, oncology, diabetes, hepatitis, cardiovascular diseases and vaccines.  Teddylab has accumulated rich experience in laboratory technology and project management in the last years .

Moreover, Teddylab also provides a high standard one-stop central laboratory service for international multi regional clinical trials (MRCT) together with our oversea strategic partner central laboratories. Teddylab has supported more than 50 MRCT clinical trials in 10+ theapeutic fields with footprints in 26 countries.